Cargando…
lncRNA PCGEM1 strengthens anti-inflammatory and lung protective effects of montelukast sodium in children with cough-variant asthma
Montelukast sodium is an effective and well-tolerated anti-asthmatic drug. Long non-coding RNAs (lncRNAs) are involved in the treatment of asthma. Therefore, this study aimed to investigate the effect of montelukast sodium on children with cough-variant asthma (CVA) and the role of lncRNA prostate c...
Autores principales: | Xu, Zhenxing, Meng, Lingling, Xie, Yuejuan, Guo, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Divulgação Científica
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7296716/ https://www.ncbi.nlm.nih.gov/pubmed/32520202 http://dx.doi.org/10.1590/1414-431X20209271 |
Ejemplares similares
-
Montelukast and budesonide combination for children with chronic cough-variant asthma
por: Wang, Xiu-ping, et al.
Publicado: (2018) -
LncRNA PCGEM1 in Human Cancers: Functions, Mechanisms and Promising Clinical Utility
por: Su, Yuanshuai, et al.
Publicado: (2022) -
A multicenter, prospective, observational study on montelukast monotherapy or montelukast-based combinations treating cough variant asthma
por: Lin, Jiangtao, et al.
Publicado: (2020) -
Clinical efficacy of montelukast sodium combined with budesonide or combined with loratadine in treating children with cough variant asthma and influence on inflammatory factors in the serum
por: Wei, Haiyan, et al.
Publicado: (2019) -
Therapeutic effect of acupuncture combined montelukast sodium on cough variant asthma in children: A protocol for systematic review and meta-analysis
por: Zhou, Xiuling, et al.
Publicado: (2021)